Trends and outcomes of percutaneous coronary intervention during the COVID-19 pandemic in Michigan.
Lorenzo AzzaliniMilan SethDevraj SukulJavier A ValleEdouard DaherBrett WanamakerMichael T TucciaroneAnwar ZaitounRyan D MadderHitinder S GurmPublished in: PloS one (2022)
During the COVID-19 pandemic, we observed a reduction in PCI volumes and higher risk-adjusted mortality. COVID-19 positive patients experienced significantly worse outcomes.
Keyphrases
- percutaneous coronary intervention
- end stage renal disease
- acute coronary syndrome
- coronary artery disease
- acute myocardial infarction
- st segment elevation myocardial infarction
- coronavirus disease
- newly diagnosed
- antiplatelet therapy
- st elevation myocardial infarction
- ejection fraction
- sars cov
- chronic kidney disease
- peritoneal dialysis
- cardiovascular events
- prognostic factors
- coronary artery bypass grafting
- heart failure
- metabolic syndrome
- risk factors
- cardiovascular disease
- type diabetes
- patient reported outcomes
- skeletal muscle
- left ventricular
- glycemic control